ResearcherSichuan UniversityActive in the last 2 years
Xing Wang
Matched on ORCID iD 0000-0003-4313-6381; OpenAlex author ID A5100365496. Sources: OpenAlex.
Their work
- Papers
- 2 (first author 1, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 6
2024: 1 paper · 2025: none · 2026: 1 paper
Papers 2
- Time to reclassify? The prognostic value of radiologic splenic vessel involvement in resectable pancreatic ductal adenocarcinoma of the body and tail: a system… Last author DOI 10.1097/js9.0000000000003927↗
- Clusterin is upregulated by erastin, a ferroptosis inducer and exerts cytoprotective effects in pancreatic adenocarcinoma cells. First author DOI 10.1097/cad.0000000000001561↗
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Xu-Bao Liu · 2 shared papers, 2024–2026 · strength 0.59
- Paper Time to reclassify? The prognostic value of radiologic splenic vessel involvement in resectable pancreatic ductal adeno… DOI 10.1097/js9.0000000000003927↗
- Paper Clusterin is upregulated by erastin, a ferroptosis inducer and exerts cytoprotective effects in pancreatic adenocarcino… DOI 10.1097/cad.0000000000001561↗
- Chunlu Tan · 2 shared papers, 2024–2026 · strength 0.59
- Paper Time to reclassify? The prognostic value of radiologic splenic vessel involvement in resectable pancreatic ductal adeno… DOI 10.1097/js9.0000000000003927↗
- Paper Clusterin is upregulated by erastin, a ferroptosis inducer and exerts cytoprotective effects in pancreatic adenocarcino… DOI 10.1097/cad.0000000000001561↗
- Qingquan Tan · 2 shared papers, 2024–2026 · strength 0.59
- Paper Time to reclassify? The prognostic value of radiologic splenic vessel involvement in resectable pancreatic ductal adeno… DOI 10.1097/js9.0000000000003927↗
- Paper Clusterin is upregulated by erastin, a ferroptosis inducer and exerts cytoprotective effects in pancreatic adenocarcino… DOI 10.1097/cad.0000000000001561↗
- Ziying Yao · 1 shared paper, 2026 · strength 0.33
- Yichen Li · 1 shared paper, 2024 · strength 0.26
- Yonghua Chen · 1 shared paper, 2024 · strength 0.26
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.